- Email: [email protected]
Keyword Index for Volume
BRAIN, BEHAVIOR, and IMMUNITY Brain, Behavior, and Immunity 20 (2006) 602–604 www.elsevier.com/locate/ybrbi
Cumulative Keyword Index for Volume 20 A ACTH, 477 Acute coronary syndromes, 113 Acute stress, 159, 410 Adrenergic receptor, 1 b-Adrenergic receptors, 201 b2-Adrenergic receptor, 1 Age, 191 Aggression, 182, 507 Aging, 201 Alcohol, 80 AMPA, 233 Amygdala, 120 Animal model, 378 Anorexia, 233 Anterior cingulate, 120 Anti-viral immunity, 552 Antibody, 1, 159 Antigen processing and presentation, 210 Antipsychotic drugs, 532 L (+)-AP3, 233 Apoptosis, 139 Associative learning, 135 Atherosclerosis, 113 Aversion, 120 B B cell, 1 Bacteria, 401 BALB/c mice, 527 BDNF, 64 Behavior, 369, 477, 569 Behavioral medicine, 27 Behaviour, 517 Bereavement, 279 Blood, 369 Blood–brain barrier, 449, 585 Body temperature, 488 Brain, 57 C C-reactive protein, 389, 456, 498 Cachexia, 233 cAMP, 552 Cardiovascular risk, 456 Catecholamines, 552 CD4 T cells, 139 CD4+ T cell, 317 CeA, 564 Chemokine, 564 doi:10.1016/S0889-1591(06)00309-6
Chronic stress, 359 Circadian, 469 Circumventricular organ, 231 Clock, 469 CNS, 449, 585 Conditioned immunosuppression, 527 Conditioned taste avoidance, 527 Conditioning, 430, 527 Cortex, 64 Corticosterone, 182, 210, 369, 477, 488 Cortisol, 40, 159, 410 CRP, 201 CSF, 585 Cyclooxygenase, 569 Cyclooxygenase-2, 325 Cyclosporine A, 527 Cynicism, 270 Cytokine system, 532 Cytokines, 1, 40, 72, 175, 270, 317, 325, 331, 339, 359, 378, 449, 507, 532, 546, 585 Cytotoxic T lymphocytes, 210 D Defensive rage, 507 Dendritic cells, 210 Dependence, 80 Depression, 80, 270, 389, 517 Depression-like behavior, 359 Developmental programming, 144 Disease resistance, 300 DNA methylation, 317 Dominance, 182 Dorsolateral prefrontal cortex, 120 E EEG, 219 Eicosanoids, 135 Elderly, 279 ELISA, 300 Emotion, 261, 517 Emotional style, 175 b-Endorphin, 9 Endothelium, 449 Endotoxin, 569 Enkephalin, 9 Epigenetics, 317 ERK, 9 ERP, 219 Evoked potentials, 219 Exercise, 201, 585 Exercise training, 139
Cumulative Keyword Index for Volume 20 / Brain, Behavior, and Immunity 20 (2006) 602–604 Expectancy, 120 Expectation, 430 Extraversion, 261 F Feeding, 569 Females, 325, 369 Fever, 233 Forced-swimming test, 517 G GABA, 507 Gastrointestinal, 578 Gastrointestinal pain, 49 Gender, 325 Gender difference, 369 Generalizability, 349 Ginseng, 546 Glucocorticoids, 590 Glucose, 401 Glucose tolerance, 401 Glutamate, 231, 233 Gram negative bacteria, 135 Granulocyte, 369 H Habituation, 456 Handedness, 349 Hantavirus, 182 Health behaviour, 389 Health disparities, 498 Helminth infection, 254 Hepatitis B vaccine, 261 Hippocampus, 64 Histone acetylation, 317 HIV-1, 552 Homeostatic Model Assessment, 331 Hopelessness, 270 Host–parasite coevolution, 182 Hostility, 389 Household occupational status, 191 HPA, 401 HPA axis, 339, 477, 564 Human, 15 Hypocortisolism, 410 Hypothalamus–pituitary–adrenal axis, 40 Hypothermia, 290 I IgG1, 1 IL-1, 72 IL-1b, 57 IL-6, 201, 389 IL-10, 460 IL-18, 201 Imipramine, 517 Immune, 9, 430 Immune challenge, 325 Immune depression, 359 Immune-to-brain signaling, 231 Immunity, 80, 169, 517, 578 Immunomodulation, 9 Indomethacin, 569 Infection, 233, 401, 498 Inflammation, 64, 144, 169, 201, 389, 423, 456, 498, 564, 578, 590
Influenza vaccination, 159, 279 Influenza virus, 339 Innate immune response, 552 Insula, 120 Insulin resistance, 331 Insulin sensitivity, 401 Insulin-like growth factor-I, 57 Interfascicular dorsal raphe nucleus, 569 Interferon, 290 Interferon-a, 552 Interferon-b, 552 Interleukin-1, 477, 507 Interleukin-2, 507 Interleukin-6, 40, 159, 246, 270 Intestinal inflammation, 254 Intestinal lymphocytes, 139 K Kainate, 233 Knockout, 290 L Laser, 219 Latent inhibition, 378 LEP, 219 Life events stress, 191 Life history strategies, 182 Lipopolysaccharide, 64, 72, 325, 517, 578 Lithium chloride, 527 LPS, 144, 233, 449 Lung, 290 Lymphocyte, 80, 349, 369 Lymphocyte proliferation, 488 Lysozyme, 300 M Major depressive disorder, 169 MAPK, 9 Marital satisfaction, 279 Marital status, 279 Maternal separation, 339 Men, 331 Metabolism, 401 MHC class I, 210 Mice, 517 Microdialysis, 477 Mitogens, 80 Monkey, 349 Monocytes, 80, 331 Mouse, 57, 359, 378 Multiple sclerosis, 27 N Natural killer, 349 Natural killer cell, 369 Natural killer cell activity, 169, 488 Negative affect, 331 Neonatal, 325 Neonatal stress, 254 Neonate, 401 Neurodevelopment, 378 Neuroendocrine–immune axis, 144 NGF, 64
603
604
Cumulative Keyword Index for Volume 20 / Brain, Behavior, and Immunity 20 (2006) 602–604
NHANES, 498 Nippostrongylus brasiliensis life cycle, 254 NK cells, 80, 469 NK-1, 507 NMDA, 233 Nocebo, 430 Norepinephrine, 1, 477 NREMS, 290 NT-3, 64 Nucleus annularis, 569 O Obesity, 585 Octopamine, 135 Opiate, 9 Opioid receptors, 15 d Opioid receptor, 9 j Opioid receptor, 9 l Opioid receptor, 9 Optimism, 261 Orbitofrontal cortex, 120 P P2, 219 Pain, 15, 219, 389 Paternity, 182 PFC, 300 Phagocytosis, 80, 369 Physical activity, 261 PKA, 552 Placebo, 15, 219, 430 Placebo effect, 219 Platelet activation, 456 Platelets, 113 Poly[rIÆrC], 290 Polyriboinosinic–polyribocytidilic acid, 378 Positive affect, 261 Positron emission tomography, 15 Postnatal, 401 Pregnancy, 378 Primary insomnia, 246 Priming, 290 Pro-inflammatory cytokines, 590 Proboscis extension, 135 Proinflammatory cytokines, 389 Protein-array, 449 Psychological stress, 40, 49, 113, 331 Psychoneuroimmunology, 1, 27, 99, 261, 389, 488 Psychosocial, 201 Psychosocial factors, 270 Psychosocial stress, 369 Public speaking stress, 49 R Rat, 64, 469 Receptor, 290 Rectal distension, 49 Reliability, 349, 456 REMS, 290 Repetitive strain injury, 423 Rhesus macaque, 349 Rhesus monkey, 564 Rhinovirus, 175 ROS, 300 Running, 578
S Saliva volume, 191 Schizophrenia, 378, 532 Secretory immunoglobulin A, 191 Selective attention, 378 Sensory nerve, 231 Serotonin, 507, 569 Sex, 191 Sex ratio, 300 Shame, 410 Sickness behavior, 57, 72 Sleep, 246, 290 Smoking, 191 Social, 300 Social evaluation, 410 Social interaction, 72 Social self-esteem, 410 Social status, 410 Social stress, 410 Social support, 279 Socioeconomic status, 498 StAR, 460 Steroidogenesis, 460 Stress, 15, 27, 300, 546, 552, 564 Stress reactivity, 410, 456 Stress severity score, 359 Stress susceptibility, 359 Stressful life events, 279 Structural equation modeling, 389 Sympathetic nervous system, 1 T T cell, 1, 9 Taste, 120 Temperature, 477 Testosterone, 349 Th1 cell, 317 Th2 cell, 317 Tilapia, 300 Tissue injury, 423 TLRs, 546 TNF, 72 TNFa, 57 Tryptophan, 569 Type I interferon, 552 U US pre-exposure effect, 378 V Vaccination response, 261 Viral infection, 210 Visceral pain, 49 Vital exhaustion, 270 W Work-related musculoskeletal disorder, 423 Wound healing, 564, 590 Y Y-1 adrenal cells, 460
Cumulative Keyword Index for Volume 20 A ACTH, 477 Acute coronary syndromes, 113 Acute stress, 159, 410 Adrenergic receptor, 1 b-Adrenergic receptors, 201 b2-Adrenergic receptor, 1 Age, 191 Aggression, 182, 507 Aging, 201 Alcohol, 80 AMPA, 233 Amygdala, 120 Animal model, 378 Anorexia, 233 Anterior cingulate, 120 Anti-viral immunity, 552 Antibody, 1, 159 Antigen processing and presentation, 210 Antipsychotic drugs, 532 L (+)-AP3, 233 Apoptosis, 139 Associative learning, 135 Atherosclerosis, 113 Aversion, 120 B B cell, 1 Bacteria, 401 BALB/c mice, 527 BDNF, 64 Behavior, 369, 477, 569 Behavioral medicine, 27 Behaviour, 517 Bereavement, 279 Blood, 369 Blood–brain barrier, 449, 585 Body temperature, 488 Brain, 57 C C-reactive protein, 389, 456, 498 Cachexia, 233 cAMP, 552 Cardiovascular risk, 456 Catecholamines, 552 CD4 T cells, 139 CD4+ T cell, 317 CeA, 564 Chemokine, 564 doi:10.1016/S0889-1591(06)00309-6
Chronic stress, 359 Circadian, 469 Circumventricular organ, 231 Clock, 469 CNS, 449, 585 Conditioned immunosuppression, 527 Conditioned taste avoidance, 527 Conditioning, 430, 527 Cortex, 64 Corticosterone, 182, 210, 369, 477, 488 Cortisol, 40, 159, 410 CRP, 201 CSF, 585 Cyclooxygenase, 569 Cyclooxygenase-2, 325 Cyclosporine A, 527 Cynicism, 270 Cytokine system, 532 Cytokines, 1, 40, 72, 175, 270, 317, 325, 331, 339, 359, 378, 449, 507, 532, 546, 585 Cytotoxic T lymphocytes, 210 D Defensive rage, 507 Dendritic cells, 210 Dependence, 80 Depression, 80, 270, 389, 517 Depression-like behavior, 359 Developmental programming, 144 Disease resistance, 300 DNA methylation, 317 Dominance, 182 Dorsolateral prefrontal cortex, 120 E EEG, 219 Eicosanoids, 135 Elderly, 279 ELISA, 300 Emotion, 261, 517 Emotional style, 175 b-Endorphin, 9 Endothelium, 449 Endotoxin, 569 Enkephalin, 9 Epigenetics, 317 ERK, 9 ERP, 219 Evoked potentials, 219 Exercise, 201, 585 Exercise training, 139
Cumulative Keyword Index for Volume 20 / Brain, Behavior, and Immunity 20 (2006) 602–604 Expectancy, 120 Expectation, 430 Extraversion, 261 F Feeding, 569 Females, 325, 369 Fever, 233 Forced-swimming test, 517 G GABA, 507 Gastrointestinal, 578 Gastrointestinal pain, 49 Gender, 325 Gender difference, 369 Generalizability, 349 Ginseng, 546 Glucocorticoids, 590 Glucose, 401 Glucose tolerance, 401 Glutamate, 231, 233 Gram negative bacteria, 135 Granulocyte, 369 H Habituation, 456 Handedness, 349 Hantavirus, 182 Health behaviour, 389 Health disparities, 498 Helminth infection, 254 Hepatitis B vaccine, 261 Hippocampus, 64 Histone acetylation, 317 HIV-1, 552 Homeostatic Model Assessment, 331 Hopelessness, 270 Host–parasite coevolution, 182 Hostility, 389 Household occupational status, 191 HPA, 401 HPA axis, 339, 477, 564 Human, 15 Hypocortisolism, 410 Hypothalamus–pituitary–adrenal axis, 40 Hypothermia, 290 I IgG1, 1 IL-1, 72 IL-1b, 57 IL-6, 201, 389 IL-10, 460 IL-18, 201 Imipramine, 517 Immune, 9, 430 Immune challenge, 325 Immune depression, 359 Immune-to-brain signaling, 231 Immunity, 80, 169, 517, 578 Immunomodulation, 9 Indomethacin, 569 Infection, 233, 401, 498 Inflammation, 64, 144, 169, 201, 389, 423, 456, 498, 564, 578, 590
Influenza vaccination, 159, 279 Influenza virus, 339 Innate immune response, 552 Insula, 120 Insulin resistance, 331 Insulin sensitivity, 401 Insulin-like growth factor-I, 57 Interfascicular dorsal raphe nucleus, 569 Interferon, 290 Interferon-a, 552 Interferon-b, 552 Interleukin-1, 477, 507 Interleukin-2, 507 Interleukin-6, 40, 159, 246, 270 Intestinal inflammation, 254 Intestinal lymphocytes, 139 K Kainate, 233 Knockout, 290 L Laser, 219 Latent inhibition, 378 LEP, 219 Life events stress, 191 Life history strategies, 182 Lipopolysaccharide, 64, 72, 325, 517, 578 Lithium chloride, 527 LPS, 144, 233, 449 Lung, 290 Lymphocyte, 80, 349, 369 Lymphocyte proliferation, 488 Lysozyme, 300 M Major depressive disorder, 169 MAPK, 9 Marital satisfaction, 279 Marital status, 279 Maternal separation, 339 Men, 331 Metabolism, 401 MHC class I, 210 Mice, 517 Microdialysis, 477 Mitogens, 80 Monkey, 349 Monocytes, 80, 331 Mouse, 57, 359, 378 Multiple sclerosis, 27 N Natural killer, 349 Natural killer cell, 369 Natural killer cell activity, 169, 488 Negative affect, 331 Neonatal, 325 Neonatal stress, 254 Neonate, 401 Neurodevelopment, 378 Neuroendocrine–immune axis, 144 NGF, 64
603
604
Cumulative Keyword Index for Volume 20 / Brain, Behavior, and Immunity 20 (2006) 602–604
NHANES, 498 Nippostrongylus brasiliensis life cycle, 254 NK cells, 80, 469 NK-1, 507 NMDA, 233 Nocebo, 430 Norepinephrine, 1, 477 NREMS, 290 NT-3, 64 Nucleus annularis, 569 O Obesity, 585 Octopamine, 135 Opiate, 9 Opioid receptors, 15 d Opioid receptor, 9 j Opioid receptor, 9 l Opioid receptor, 9 Optimism, 261 Orbitofrontal cortex, 120 P P2, 219 Pain, 15, 219, 389 Paternity, 182 PFC, 300 Phagocytosis, 80, 369 Physical activity, 261 PKA, 552 Placebo, 15, 219, 430 Placebo effect, 219 Platelet activation, 456 Platelets, 113 Poly[rIÆrC], 290 Polyriboinosinic–polyribocytidilic acid, 378 Positive affect, 261 Positron emission tomography, 15 Postnatal, 401 Pregnancy, 378 Primary insomnia, 246 Priming, 290 Pro-inflammatory cytokines, 590 Proboscis extension, 135 Proinflammatory cytokines, 389 Protein-array, 449 Psychological stress, 40, 49, 113, 331 Psychoneuroimmunology, 1, 27, 99, 261, 389, 488 Psychosocial, 201 Psychosocial factors, 270 Psychosocial stress, 369 Public speaking stress, 49 R Rat, 64, 469 Receptor, 290 Rectal distension, 49 Reliability, 349, 456 REMS, 290 Repetitive strain injury, 423 Rhesus macaque, 349 Rhesus monkey, 564 Rhinovirus, 175 ROS, 300 Running, 578
S Saliva volume, 191 Schizophrenia, 378, 532 Secretory immunoglobulin A, 191 Selective attention, 378 Sensory nerve, 231 Serotonin, 507, 569 Sex, 191 Sex ratio, 300 Shame, 410 Sickness behavior, 57, 72 Sleep, 246, 290 Smoking, 191 Social, 300 Social evaluation, 410 Social interaction, 72 Social self-esteem, 410 Social status, 410 Social stress, 410 Social support, 279 Socioeconomic status, 498 StAR, 460 Steroidogenesis, 460 Stress, 15, 27, 300, 546, 552, 564 Stress reactivity, 410, 456 Stress severity score, 359 Stress susceptibility, 359 Stressful life events, 279 Structural equation modeling, 389 Sympathetic nervous system, 1 T T cell, 1, 9 Taste, 120 Temperature, 477 Testosterone, 349 Th1 cell, 317 Th2 cell, 317 Tilapia, 300 Tissue injury, 423 TLRs, 546 TNF, 72 TNFa, 57 Tryptophan, 569 Type I interferon, 552 U US pre-exposure effect, 378 V Vaccination response, 261 Viral infection, 210 Visceral pain, 49 Vital exhaustion, 270 W Work-related musculoskeletal disorder, 423 Wound healing, 564, 590 Y Y-1 adrenal cells, 460